S J Taler
Affiliation: Mayo Clinic
- Individualizing antihypertensive combination therapies: clinical and hemodynamic considerationsSandra J Taler
Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
Curr Hypertens Rep 16:451. 2014..The potential utility of this approach increases with greater complexity of the medication regimen. Further studies are indicated and may advance options for individualized treatment of hypertensive patients. ..
- Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decadesS J Taler
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
Am J Transplant 13:390-8. 2013..The fraction of older donors accepted with glucose intolerance or hypertension remains small and for the majority includes mild elevations in glucose or blood pressure that were previously classified as within normal limits...
- Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulationsS J Taler
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Hypertens 13:231-9. 2000..5%, normal 13%), usually absent early after transplantation. Our results demonstrate the ability of hemodynamic measurements to predict the symptomatic response to antihypertensive therapy in the posttransplant setting...
- Hypertension in womenSandra J Taler
Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
Curr Hypertens Rep 11:23-8. 2009..There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women...
- Secondary causes of hypertensionSandra J Taler
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Prim Care 35:489-500, vi. 2008..Referral is advised when these risks seem prohibitive or if there are questions regarding the selection of the most optimal studies or the extent of intervention to pursue when blood pressure remains uncontrolled...
- Resistant hypertension: comparing hemodynamic management to specialist careSandra J Taler
Department of Medicine, Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Hypertension 39:982-8. 2002....
- Should chlorthalidone be the diuretic of choice for antihypertensive therapy?Sandra J Taler
Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Curr Hypertens Rep 10:293-7. 2008..This review presents the data available on both sides of this issue to help the reader decide which claims are most valid, and offers recommendations for treatment...
- Treatment of resistant hypertensionSandra J Taler
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Curr Hypertens Rep 7:323-9. 2005..Determination of the most effective approaches will require clinical trials using combination therapy...
- Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapyS J Taler
Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Am J Hypertens 8:598-605. 1995..Both immunosuppressive regimens led to a loss of nocturnal blood pressure fall, as compared to ESLD patients or normotensive controls.(ABSTRACT TRUNCATED AT 250 WORDS)..
- Posttransplantation hypertension related to calcineurin inhibitorsS C Textor
Department of Medicine, Division of Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 6:521-30. 2000..Attention must be paid to interactions between antihypertensive agents and calcineurin inhibitor blood levels...
- Glomerular volume and renal histology in obese and non-obese living kidney donorsD J Rea
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55904, USA
Kidney Int 70:1636-41. 2006..08). From these data, our studies detected subtle differences in donor organs obtained from obese compared to non-obese individuals. Further studies should be carried out to quantify the long-term impact of these findings...
- Living donor age and kidney transplant outcomesK Noppakun
Division of Nephrology and Hypertension, Department of Internal Medicine and William von Liebig transplant Center, Mayo Clinic, Rochester, MN, USA
Am J Transplant 11:1279-86. 2011..In conclusion, LD age is an important determinant of long-term graft survival, particularly in younger recipients. Older kidneys with reduced survival are identifiable by the development of proteinuria posttransplant...
- Hypertension in women: current understanding of gender differencesS N Hayes
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA
Mayo Clin Proc 73:157-65. 1998..These studies suggest that, although gender differences exist, women benefit significantly when they receive therapy to normalize blood pressure...
- Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomyJulie K Heimbach
Mayo Clinic College of Medicine, Department of Transplant Surgery, Rochester, Minnesota, USA
Am J Transplant 5:1057-64. 2005..While early results are encouraging, we advocate careful study of obese donors and do not support their widespread use until longer follow-up is available...
- Blood pressure evaluation among older living kidney donorsStephen C Textor
Department of Internal Medicine, Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, Minnesota, USA
J Am Soc Nephrol 14:2159-67. 2003..Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors...
- Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive indexHani M Wadei
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
J Am Soc Nephrol 18:1607-15. 2007..Further studies are needed to determine whether restoration of normal BP pattern will confer better allograft outcome...
- Blood pressure and renal function after kidney donation from hypertensive living donorsStephen C Textor
Department of Medicine, Divisions of Nephrology and Hypertension, W9A, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Transplantation 78:276-82. 2004..This study reports outcomes of hypertensive donors 1 year after kidney donation...
- Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFRLourdes S Peña de la Vega
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Kidney Int 66:1654-61. 2004..Donor age adversely affects deceased-donor kidney transplant outcomes, but its influence on living-donor transplantation is less well characterized...
- Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomyHatem Amer
J Urol 180:780. 2008
- Toward optimal health: the experts discuss hypertension [interview by Jodi Godfrey Meisler]Sandra J Taler
J Womens Health Gend Based Med 11:111-7. 2002
- Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision makingHector O Ventura
Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 18:26S-43S. 2005..This article reviews the importance of hemodynamic factors in hypertension and the evolving role of ICG technology in the assessment and management of this important cardiovascular condition...
- The health status of Caucasian and African American living with kidney donorsSandra Taler; Fiscal Year: 2007....